发明名称 |
Drug Delivery Methods and Systems |
摘要 |
Drug delivery methods and systems that include a determination of whether a cardiac condition is normal or abnormal, so that a drug may be administered in accordance with that determination. In one implementation, a drug delivery device may be controlled to reduce or stop the drug administration when a normal cardiac condition is detected. In another implementation, a patient monitoring device determines the duration that a cardiac condition is normal and provides an output indicative of the determination so that the patient may alter a therapy accordingly.
|
申请公布号 |
US2012029372(A1) |
申请公布日期 |
2012.02.02 |
申请号 |
US201113271717 |
申请日期 |
2011.10.12 |
申请人 |
HAEFNER PAUL A.;MOON LOELL BOYCE;GREATBATCH LTD. |
发明人 |
HAEFNER PAUL A.;MOON LOELL BOYCE |
分类号 |
A61B5/0452;A61B5/02;A61M5/168 |
主分类号 |
A61B5/0452 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|